Free Trial

Hims & Hers Health (HIMS) Competitors

$16.10
-0.18 (-1.11%)
(As of 09/17/2024 ET)

HIMS vs. FMS, PACS, OPCH, SHC, SGRY, GH, CON, LFST, ARDT, and VCYT

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Fresenius Medical Care (FMS), PACS Group (PACS), Option Care Health (OPCH), Sotera Health (SHC), Surgery Partners (SGRY), Guardant Health (GH), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), Ardent Health Partners (ARDT), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs.

Fresenius Medical Care (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.

Fresenius Medical Care received 382 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 54.40% of users gave Fresenius Medical Care an outperform vote while only 35.16% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Fresenius Medical CareOutperform Votes
414
54.40%
Underperform Votes
347
45.60%
Hims & Hers HealthOutperform Votes
32
35.16%
Underperform Votes
59
64.84%

Fresenius Medical Care has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care$19.42B0.63$540.07M$0.8923.45
Hims & Hers Health$1.07B3.23-$23.55M-$0.01-1,607.00

Fresenius Medical Care has a net margin of 2.72% compared to Hims & Hers Health's net margin of 1.70%. Fresenius Medical Care's return on equity of 5.48% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care2.72% 5.48% 2.41%
Hims & Hers Health 1.70%5.25%4.06%

8.3% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Fresenius Medical Care has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.

In the previous week, Hims & Hers Health had 9 more articles in the media than Fresenius Medical Care. MarketBeat recorded 18 mentions for Hims & Hers Health and 9 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.07 beat Hims & Hers Health's score of 0.40 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care
6 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
8 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care currently has a consensus price target of $22.00, indicating a potential upside of 5.36%. Hims & Hers Health has a consensus price target of $19.86, indicating a potential upside of 22.42%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Fresenius Medical Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hims & Hers Health
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Fresenius Medical Care and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$3.45B$679.22M$5.50B$18.94B
Dividend YieldN/AN/A4.27%3.55%
P/E Ratio-1,607.0041.00146.6326.43
Price / Sales3.230.931,739.9115.78
Price / CashN/A57.7836.7619.83
Price / Book9.987.014.835.09
Net Income-$23.55M-$50.09M$114.56M$980.71M
7 Day Performance10.56%9.01%5.61%3.98%
1 Month Performance3.15%-4.39%9.33%3.59%
1 Year Performance154.68%-17.61%28.79%17.86%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care
3.1342 of 5 stars
3.13 / 5 stars
$21.09
+4.5%
$22.00
+4.3%
-6.8%$12.38B$21.05B23.701,358Analyst Forecast
Short Interest ↑
News Coverage
Positive News
High Trading Volume
PACS
PACS Group
2.5071 of 5 stars
2.51 / 5 stars
$40.72
+1.8%
$37.57
-7.7%
N/A$6.21B$3.56B0.0032,433
OPCH
Option Care Health
4.9239 of 5 stars
4.92 / 5 stars
$31.99
+0.6%
$39.50
+23.5%
-10.3%$5.56B$4.59B21.057,802Positive News
SHC
Sotera Health
2.5814 of 5 stars
2.58 / 5 stars
$16.80
+1.9%
$15.70
-6.5%
+7.1%$4.76B$1.05B88.433,000
SGRY
Surgery Partners
4.1121 of 5 stars
4.11 / 5 stars
$31.00
+3.5%
$39.86
+28.6%
+0.5%$3.94B$2.74B42.8913,500Positive News
GH
Guardant Health
4.4219 of 5 stars
4.42 / 5 stars
$26.79
+4.7%
$39.31
+46.7%
-15.0%$3.28B$643.81M-6.831,779Short Interest ↑
News Coverage
CON
Concentra Group Holdings Parent
0 of 5 stars
0.00 / 5 stars
$23.18
+2.7%
$29.69
+28.1%
N/A$2.93B$1.84B0.00N/APositive News
LFST
LifeStance Health Group
1.6437 of 5 stars
1.64 / 5 stars
$6.94
+0.6%
$8.25
+18.9%
-2.6%$2.66B$1.06B-14.469,325Positive News
ARDT
Ardent Health Partners
0 of 5 stars
0.00 / 5 stars
$18.15
+1.2%
$21.70
+19.6%
N/A$2.59BN/A0.0024,200Positive News
VCYT
Veracyte
3.8748 of 5 stars
3.87 / 5 stars
$32.92
+8.2%
$31.25
-5.1%
+37.0%$2.53B$361.05M-35.02790Gap Up

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners